BioLife Solutions, Inc. Increase (Decrease) in Deferred Liabilities
BioLife Solutions, Inc. (BLFS) reported Increase (Decrease) in Deferred Liabilities of -$16.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredLiabilities · last filed 2019-03-15
- BioLife Solutions, Inc. increase (decrease) in deferred liabilities for fiscal 2018 was -$16.00K.
- BioLife Solutions, Inc. increase (decrease) in deferred liabilities for fiscal 2017 was -$65.00K, a 332.23% decline from fiscal 2016.
- BioLife Solutions, Inc. increase (decrease) in deferred liabilities for fiscal 2016 was $27.99K.
| Period end | Increase (Decrease) in Deferred Liabilities 12 month | Increase (Decrease) in Deferred Liabilities 12 month as first filed |
|---|---|---|
| 2018-12-31 | -$16.00K 10-K · filed 2019-03-15 | |
| 2017-12-31 | -$65.00K 10-K · filed 2019-03-15 | -$66.25K 10-K · filed 2018-03-09 |
| 2016-12-31 | $27.99K 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |